Streff, Alyssa
Chu-Pilli, Michele
Stopeck, Alison
Chalasani, Pavani
Funding for this research was provided by:
National Cancer Institute (P30 CA 023074-34)
Article History
Received: 24 July 2019
Accepted: 13 April 2020
First Online: 23 April 2020
Compliance with ethical standards
:
: Dr. Alyssa Streff and Michelle Chu-Pilli report no conflict of interest.Dr. Alison Stopeck reports grants and personal fees from Amgen, personal fees from Novartis, personal fees from Biothera, personal fees from Pfizer, personal fees from AstraZeneca, grants from Seattle Genetics. None of these funding sources are involved/overlap with the current submitted trial.Dr. Pavani Chalasani reports research funding from Pzifer, advisory boards for Nanostring, Heron therapeutics, Astrazeneca, Amgen, Bayer, Novartis. None of these funding sources are involved/overlap with the current submitted trial.